<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>References</title><link href="navigation.css" rel="stylesheet" type="text/css"/><link href="document.css" rel="stylesheet" type="text/css"/></head><body><p class="top_nav"><a href="part31.htm">&lt; 上一个</a><span> | </span><a href="../j.jaad.2018.10.079.html">内容</a></p><p class="s23" style="padding-top: 4pt;padding-left: 5pt;text-indent: 11pt;line-height: 108%;text-align: justify;"><a href="http://www.peelingsociety.com/home/" style=" color: black; font-family:Garamond, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt;" target="_blank" name="bookmark31">We thank Pearl Grimes, MD, for her contribution of photographs for this manuscript and the reviewers and the members of the International Peeling Society (</a><span style=" color: #007FAC; font-family:Garamond, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt;">http://www.peelingsociety.com/home/</span>) for their diligence in compiling and reviewing this article.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s34" style="padding-left: 5pt;text-indent: 0pt;text-align: left;"><a name="bookmark50">REFERENCES</a></p><p class="s18" style="padding-left: 19pt;text-indent: -9pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref1" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark51">1. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref1" class="a" target="_blank">Brody HJ, Monheit GD, Resnik SS, Alt TH. A history of chemical peeling. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref1" class="s35" target="_blank">Dermatol Surg</a>. 2000;26:405-409<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -9pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref2" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">2. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref2" class="a" target="_blank">Berson DS, Cohen JL, Rendon MI, Roberts WE, Starker I, Wang B. Clinical role and application of superficial chemical peels in today’s practice. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref2" class="s35" target="_blank">J Drugs Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref2" class="a" target="_blank">. 2009;8: </a>803-811<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -9pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref3" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">3. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref3" class="a" target="_blank">Fischer TC, Perosino E, Poli F, Viera MS, Dreno B, Cosmetic Dermatology European Expert Group. Chemical peels in aesthetic dermatology: an update 2009. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref3" class="s35" target="_blank">J Eur Acad Dermatol Venereol</a>. 2010;24:281-292<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref4" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark52">4. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref4" class="a" target="_blank">Monheit GD. Chemical peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref4" class="s35" target="_blank">Skin Therapy Lett</a>. 2004;9:6-11<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -9pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref5" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">5. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref5" class="a" target="_blank">Botta SA, Straith RE, Goodwin HH. Cardiac arrhythmias in phenol face peeling: a suggested protocol for prevention. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref5" class="s35" target="_blank">Aesthet Plast Surg</a>. 1988;12:115-117<span style=" color: #000;">.</span></p><p style="padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref6" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">6. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref6" target="_blank">Gross BG. Cardiac arrhythmias during phenol face peeling.</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref6" class="s35" target="_blank" name="bookmark53">Plast Reconstr Surg</a>. 1984;73:590-594<span style=" color: #000;">.</span></p><p style="text-indent: 0pt;line-height: 8pt;text-align: left;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref7">e</a></p><p style="text-indent: 0pt;line-height: 8pt;text-align: left;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref7">e</a></p><p style="text-indent: 0pt;text-align: left;"/><p style="text-indent: 0pt;line-height: 8pt;text-align: left;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref7">e</a></p><p class="s18" style="padding-left: 19pt;text-indent: -9pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref7" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark54">7. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref7" class="a" target="_blank">Magalhaes G, Borges M, Queiroz A, Capp A, Pedrosa S, Diniz M. Double-blind randomized study of 5% and 10% retinoic acid peels in the treatment of melasma: clinical evaluation and impact on the quality of life. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref7" class="s35" target="_blank">Surg Cosmet Dermatol</a>. 2011;3:17-22<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -9pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref8" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark55">8. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref8" class="a" target="_blank">Sumita J, Soares J, Tannus F, Miot H, Bagatin E. Tretinoin 5% peeling versus 0.05% cream for advanced photoaging of the forearms: an open, randomized, evaluator-blinded and compar- ative study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref8" class="s35" target="_blank">J Am Acad Dermatol</a>. 2017;76(6 suppl 1):AB269<span style=" color: #000;">.</span></p><p style="padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref9" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">9. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref9" target="_blank">Chiabrando C, Castelli MG, Cozzi E, et al. Antiinflammatory action</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref9" class="a" target="_blank" name="bookmark56">of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref9" class="s35" target="_blank">Eur J Pharmacol</a>. 1989;159:257-264<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref10" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark57">10. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref10" class="a" target="_blank">Bandara M, Sankaridurg P, Zhu H, Hume E, Willcox M. Effect of salicylic acid on the membrane proteome and virulence of </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref10" class="s35" target="_blank">Pseudomonas aeruginosa</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref10" class="a" target="_blank">. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref10" class="s35" target="_blank">Invest Ophthalmol Vis Sci</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref10" class="a" target="_blank">. 2016;57: </a>1213-1220<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref11" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark58">11. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref11" class="a" target="_blank">Chang TS. An updated review of tyrosinase inhibitors. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref11" class="s35" target="_blank">Int J Mol Sci</a>. 2009;10:2440-2475<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref12" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark59">12. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref12" class="a" target="_blank">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref12" class="s35" target="_blank">Dermatol Surg</a>. 1999;25:18-22<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref13" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark60">13. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref13" class="a" target="_blank">Dainichi T, Ueda S, Imayama S, Furue M. Excellent clinical results with a new preparation for chemical peeling in acne: 30% salicylic acid in polyethylene glycol vehicle. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref13" class="s35" target="_blank">Dermatol Surg</a>. 2008;34:891-899<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref14" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark61">14. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref14" class="a" target="_blank">Dainichi T, Amano S, Matsunaga Y, et al. Chemical peeling by SA-PEG remodels photo-damaged skin: suppressing p53 expression and normalizing keratinocyte differentiation. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref14" class="s35" target="_blank">J Invest Dermatol</a>. 2006;126:416-421<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/6421" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark62">15. National Center for Biotechnology Information website. Com- pound summary. Trichloroacetic acid. Available at: </a><a href="https://pubchem.ncbi.nlm.nih.gov/compound/6421" class="a" target="_blank">https:// </a>pubchem.ncbi.nlm.nih.gov/compound/6421<span style=" color: #000;">. Accessed April 12, 2018.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref16" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark63">16. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref16" class="a" target="_blank">Bridenstine JB, Dolezal JF. Standardizing chemical peel solu- tion formulations to avoid mishaps. Great fluctuations in actual concentrations of trichloroacetic acid. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref16" class="s35" target="_blank">J Dermatol Surg Oncol</a>. 1994;20:813-816<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref17" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">17. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref17" class="a" target="_blank">Wambier C, Brody H. Classification of chemical peels. In: da Costa A, ed. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref17" class="s35" target="_blank">Minimally Invasive Aesthetic Procedures for Dermatologists and Plastic Surgeons</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref17" class="a" target="_blank">. Atlanta, GA: Springer </a>Nature; 2019:1-12<span style=" color: #000;">.</span></p><p class="s18" style="padding-top: 3pt;padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref18" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark64">18. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref18" class="a" target="_blank">Brody HJ. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref18" class="s35" target="_blank">Chemical Peeling and Resurfacing</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref18" class="a" target="_blank">. 3rd ed. Atlanta, GA: Emory University Digital Library Publications; </a>2009:1-267<span style=" color: #000;">.</span><a name="bookmark65">&zwnj;</a></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref19" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark66">19. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref19" class="a" target="_blank">Ayres F, Wambier C. Phenol-croton oil peels. In: da Costa A, ed. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref19" class="s35" target="_blank">Minimally Invasive Aesthetic Procedures for Dermatologists and Plastic Surgeons</a>. Atlanta, GA: Springer Nature; 2019<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref20" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">20.  </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref20" class="a" target="_blank">Gaspar NG, Gaspar APA, Ai</a>d<span class="s37">^</span><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref20" class="a" target="_blank">e MK. Rhinophyma: practical </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref20" target="_blank">and</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref20" class="a" target="_blank" name="bookmark67">safe treatment with trichloroacetic acid. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref20" class="s35" target="_blank">Surg Cosmet Derma- tol</a>. 2014;6:368-372<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref21" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">21. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref21" class="a" target="_blank">Yug A, Lane JE, Howard MS, Kent DE. Histologic study of depressed acne scars treated with serial high-concentration (95%) trichloroacetic acid. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref21" class="s35" target="_blank">Dermatol Surg</a>. 2006;32:985-990<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref22" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">22. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref22" target="_blank">Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref22" class="a" target="_blank">scars with trichloroacetic acid: chemical reconstruction of skin scars method. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref22" class="s35" target="_blank">Dermatol Surg</a>. 2002;28:1017-1021<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref23" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">23. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref23" class="a" target="_blank">Dalpizzol M, Weber MB, Mattiazzi AP, Manzoni AP. Compara- tive study of the use of trichloroacetic acid and phenolic acid in the treatment of atrophic-type acne scars. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref23" class="s35" target="_blank">Dermatol Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref23" class="a" target="_blank">. </a>2016;42:377-383<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">24.  </a>Mu<a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="s38" target="_blank">€</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="a" target="_blank">hlmann AC, Macedo Fonseca JC, Bai</a><span class="s37">~</span><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="a" target="_blank">ao Fernando G, Chiara Moc¸o L. Estudo comparativo entre </a>aplicac¸<span class="s37">~</span><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="a" target="_blank">ao de ATA a 90% e fenol a 88% com a </a>t<a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="s38" target="_blank">&#39;</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="a" target="_blank">ecnica de CROSS nas cicatrizes da </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" target="_blank">acne.</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref24" class="s35" target="_blank">Med Cutan Ibero Lat Am</a>. 2010;38:189-193<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref25" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">25. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref25" class="a" target="_blank">Nofal E, Helmy A, Nofal A, Alakad R, Nasr M. Platelet-rich plasma versus CROSS technique with 100% trichloroacetic acid versus combined skin needling and platelet rich plasma in the treatment of atrophic acne scars: a comparative study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref25" class="s35" target="_blank">Dermatol Surg</a>. 2014;40:864-873<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref26" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark68">26. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref26" class="a" target="_blank">Rullan PP, Lemon J, Rullan J. The 2-day light phenol chemabrasion for deep wrinkles and acne scars: a presenta- tion of face and neck peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref26" class="s35" target="_blank">Am J Cosmet Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref26" class="a" target="_blank">. 2004;21:199- </a>210<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref27" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">27. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref27" class="a" target="_blank">de Mendonca MC, de Oliveira AR, Araujo JM, Silva M, Gamonal A. Nonsurgical technique for incomplete earlobe cleft repair. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref27" class="s35" target="_blank">Dermatol Surg</a>. 2009;35:446-450<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref28" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">28. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref28" target="_blank">Muthuvel K, Sekar S, MS D. Incomplete ear lobe cleft repair</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref28" class="a" target="_blank" name="bookmark69">with 100% trichloroacetic acid. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref28" class="s35" target="_blank">Int J Res Dermatol</a>. 2016;2:91<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref29" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">29. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref29" class="a" target="_blank">Haque MU, Ramesh V. Evaluation of three different strengths of trichloroacetic acid in xanthelasma palpebrarum. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref29" class="s35" target="_blank">J Derma- tolog Treat</a>. 2006;17:48-50<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref30" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">30. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref30" class="a" target="_blank">Cannon PS, Ajit R, Leatherbarrow B. Efficacy of trichloroacetic acid (95%) in the management of xanthelasma palpebrarum. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref30" class="s35" target="_blank">Clin Exp Dermatol</a>. 2010;35:845-848<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref31" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">31. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref31" target="_blank">Nahas TR, Marques JC, Nicoletti A, Cunha M, Nishiwaki-</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref31" class="a" target="_blank" name="bookmark70">Dantas MC, Filho JV. Treatment of eyelid xanthelasma with 70% trichloroacetic acid. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref31" class="s35" target="_blank">Ophthal Plast Reconstr Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref31" class="a" target="_blank">. 2009;25: </a>280-283<span style=" color: #000;">.</span></p><p class="s16" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;">32. Wambier CG. Chemical peels. Presented at the 2018 American Academy of Dermatology Annual Meeting, San Diego, CA, February 16-20, 2018.</p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref33" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark71">33. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref33" class="a" target="_blank">Safoury OS, Zaki NM, El Nabarawy EA, Farag EA. A study comparing chemical peeling using modified Jessner’s solution and 15% trichloroacetic acid versus 15% trichloroacetic acid in the treatment of melasma. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref33" class="s35" target="_blank">Indian J Dermatol</a>. 2009;54:41-45<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref34" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">34. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref34" target="_blank">Abdel-Meguid AM, Taha EA, Ismail SA. Combined Jessner</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref34" class="a" target="_blank">solution and trichloroacetic acid versus trichloroacetic acid alone in the treatment of melasma in dark-skinned patients. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref34" class="s35" target="_blank">Dermatol Surg</a>. 2017;43:651-656<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref35" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">35. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref35" target="_blank">Brody HJ. Commentary on combined Jessner solution and</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref35" class="a" target="_blank" name="bookmark72">trichloroacetic acid versus trichloroacetic acid alone in the treatment of melasma in dark-skinned patients. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref35" class="s35" target="_blank">Dermatol Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref35" class="a" target="_blank">. </a>2017;43:657<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref36" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">36. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref36" class="a" target="_blank">Brody HJ. Variations and comparisons in medium-depth chemical peeling. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref36" class="s35" target="_blank">J Dermatol Surg Oncol</a>. 1989;15:953-963<span style=" color: #000;">.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s18" style="padding-top: 3pt;padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref37" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark73">37. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref37" class="a" target="_blank">Brody HJ, Hailey CW. Medium-depth chemical peeling of the skin: a variation of superficial chemosurgery. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref37" class="s35" target="_blank">J Dermatol Surg Oncol</a>. 1986;12:1268-1275<span style=" color: #000;">.</span><a name="bookmark74">&zwnj;</a></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref38" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark75">38. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref38" class="a" target="_blank">Tse Y, Ostad A, Lee HS, et al. A clinical and histologic evaluation of two medium-depth peels. Glycolic acid versus Jessner’s trichloroacetic acid. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref38" class="s35" target="_blank">Dermatol Surg</a>. 1996;22:781-786<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref39" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">39. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref39" target="_blank">Coleman WP 3rd, Futrell JM. The glycolic acid trichloroacetic</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref39" class="a" target="_blank" name="bookmark76">acid peel. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref39" class="s35" target="_blank">J Dermatol Surg Oncol</a>. 1994;20:76-80<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref40" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark77">40. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref40" class="a" target="_blank">Nelson BR, Fader DJ, Gillard M, Majmudar G, Johnson TM. Pilot histologic and ultrastructural study of the effects of medium- depth chemical facial peels on dermal collagen in patients with actinically damaged skin. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref40" class="s35" target="_blank">J Am Acad Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref40" class="a" target="_blank">. 1995;32: </a>472-478<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref41" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark78">41. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref41" class="a" target="_blank">Monheit GD. The Jessner’s-trichloroacetic acid peel. An enhanced medium-depth chemical peel. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref41" class="s35" target="_blank">Dermatol Clin</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref41" class="a" target="_blank">. 1995; </a>13:277-283<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref42" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark79">42. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref42" class="a" target="_blank">Monheit GD. The Jessner’s 1 TCA peel: a medium-depth chemical peel. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref42" class="s35" target="_blank">J Dermatol Surg Oncol</a>. 1989;15:945-950<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref43" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">43. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref43" class="a" target="_blank">Ormerod E, Hughes TM, Stone N. Allergic contact dermatitis caused by resorcinol following a temporary black henna tattoo. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref43" class="s35" target="_blank">Contact Dermatitis</a>. 2017;77:187-188<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref44" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">44. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref44" target="_blank">Pastor-Nieto MA, Sanchez-Pedreno P, Martinez-Menchon T,</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref44" class="a" target="_blank">Melgar-Molero V, Alcantara-Nicolas F, de la Cruz-Murie P. Allergic contact dermatitis caused by phenylethyl resorcinol, a skin-lightening agent contained in a sunscreen. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref44" class="s35" target="_blank">Contact Dermatitis</a>. 2016;75:250-253<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref45" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark80">45. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref45" class="a" target="_blank">Langeland T, Braathen LR. Allergic contact dermatitis from resorcinol. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref45" class="s35" target="_blank">Contact Dermatitis</a>. 1987;17:126<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref46" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark81">46. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref46" class="a" target="_blank">Maloney BP, Millman B, Monheit G, McCollough EG. The etiology of prolonged erythema after chemical peel. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref46" class="s35" target="_blank">Dermatol Surg</a>. 1998;24:337-341<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref47" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">47. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref47" class="a" target="_blank">Wambier CG, Beltrame FL. Air safety and personal protective equipment for phenol-croton oil peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref47" class="s35" target="_blank">Dermatol Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref47" class="a" target="_blank">. 2018; </a>44:1035-1037<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref48" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark82">48. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref48" class="a" target="_blank">Wambier CG, Wambier SPF, Pilatti LEP, Grabicoski JA, Wambier LF, Schmidt A. Prolongation of rate-corrected QT interval during phenol-croton oil peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref48" class="s35" target="_blank">J Am Acad Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref48" class="a" target="_blank">. </a>2018;78:810-812<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref49" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark83">49. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref49" class="a" target="_blank">Camacho FM. Medium-depth and deep chemical peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref49" class="s35" target="_blank">J Cosmet Dermatol</a>. 2005;4:117-128<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref50" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark84">50. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref50" class="a" target="_blank">de Mendonca MCC, Segheto NN, Aarestrup FM, Aarestrup BJV. Punctuated 88% phenol peeling for the treatment of facial photoaging: a clinical and histopathological study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref50" class="s35" target="_blank">Dermatol Surg</a>. 2018;44:241-247<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref51" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">51. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref51" class="a" target="_blank">Al-Talib H, Al-Khateeb A, Hameed A, Murugaiah C. Efficacy and safety of superficial chemical peeling in treatment of active acne vulgaris. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref51" class="s35" target="_blank">An Bras Dermatol</a>. 2017;92:212-216<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref52" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">52. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref52" target="_blank">Dayal S, Amrani A, Sahu P, Jain VK. Jessner’s solution vs. 30%</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref52" class="a" target="_blank">salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref52" class="s35" target="_blank">J Cosmet Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref52" class="a" target="_blank">. </a>2017;16:43-51<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref53" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark85">53. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref53" class="a" target="_blank">Kligman DE, Draelos ZD. Combination superficial peels with salicylic acid and post-peel retinoids. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref53" class="s35" target="_blank">J Drugs Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref53" class="a" target="_blank">. 2016; </a>15:442-450<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref54" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark86">54. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref54" class="a" target="_blank">Vemula S, Maymone MBC, Secemsky EA, et al. Assessing the safety of superficial chemical peels in darker skin: a retrospec- tive study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref54" class="s35" target="_blank">J Am Acad Dermatol</a>. 2018;79:508-513.e2<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref55" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">55. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref55" target="_blank">Kessler E, Flanagan K, Chia C, Rogers C, Glaser DA. Comparison</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref55" class="a" target="_blank" name="bookmark87">of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref55" class="s35" target="_blank">Dermatol Surg</a>. 2008;34:45-50<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref56" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">56. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref56" target="_blank">Garg VK, Sinha S, Sarkar R. Glycolic acid peels versus salicylic-</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref56" class="a" target="_blank">mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation: a comparative study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref56" class="s35" target="_blank">Der- matol Surg</a>. 2009;35:59-65<span style=" color: #000;">.</span></p><p class="s18" style="padding-top: 3pt;padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref57" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark88">57. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref57" class="a" target="_blank">Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref57" class="s35" target="_blank">J Am Acad Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref57" class="a" target="_blank">. </a>2001;45:109-117<span style=" color: #000;">.</span><a name="bookmark89">&zwnj;</a></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref58" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark90">58. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref58" class="a" target="_blank">Al-Waiz MM, Al-Sharqi AI. Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref58" class="s35" target="_blank">Dermatol Surg</a>. 2002;28:383-387<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref59" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark91">59. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref59" class="a" target="_blank">Brodland DG, Roenigk RK. Trichloroacetic acid chemexfoliation (chemical peel) for extensive premalignant actinic damage of the face and scalp. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref59" class="s35" target="_blank">Mayo Clin Proc</a>. 1988;63:887-896<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref60" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">60. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref60" target="_blank">Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr. A</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref60" class="a" target="_blank" name="bookmark92">comparison of the efficacy and safety of Jessner’s solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref60" class="s35" target="_blank">Arch Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref60" class="a" target="_blank">. 1995;131: </a>176-181<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref61" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark93">61. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref61" class="a" target="_blank">Witheiler DD, Lawrence N, Cox SE, Cruz C, Cockerell CJ, Freemen RG. Long-term efficacy and safety of Jessner’s solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref61" class="s35" target="_blank">Dermatol Surg</a>. 1997;23:191-196<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref62" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark94">62. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref62" class="a" target="_blank">Robinson JK. Actinic cheilitis. A prospective study comparing four treatment methods. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref62" class="s35" target="_blank">Arch Otolaryngol Head Neck Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref62" class="a" target="_blank">. </a>1989;115:848-852<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref63" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark95">63. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref63" class="a" target="_blank">Funasaka Y, Abdel-Daim M, Kawana S, Nishigori C. Effect of chemical peeling on the skin in relation to UV irradiation. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref63" class="s35" target="_blank">Exp Dermatol</a>. 2012;21(suppl 1):31-35<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref64" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">64. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref64" class="a" target="_blank">Abdel-Daim M, Funasaka Y, Kamo T, et al. Effect of chemical peeling on photocarcinogenesis. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref64" class="s35" target="_blank">J Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref64" class="a" target="_blank">. </a>2010;37:864-872<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref65" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark96">65. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref65" class="a" target="_blank">Abdel-Daim M, Funasaka Y, Kamo T, et al. Preventive effect of chemical peeling on ultraviolet induced skin tumor formation. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref65" class="s35" target="_blank">J Dermatol Sci</a>. 2010;60:21-28<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref66" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">66. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref66" target="_blank">Kontochristopoulos G, Kouris A, Platsidaki E, Markantoni V,</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 106%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref66" class="a" target="_blank" name="bookmark97">Gerodimou M, Antoniou C. Combination of microneedling and 10% trichloroacetic acid peels in the management of infraorbital dark circles. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref66" class="s35" target="_blank">J Cosmet Laser Ther</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref66" class="a" target="_blank">. 2016;18: </a>289-292<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref67" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark98">67. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref67" class="a" target="_blank">Vavouli C, Katsambas A, Gregoriou S, et al. Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref67" class="s35" target="_blank">J Cosmet Dermatol</a>. 2013;12:204-209<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref68" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">68. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref68" target="_blank">Dayal S, Sahu P, Jain VK, Khetri S. Clinical efficacy and safety of</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref68" class="a" target="_blank" name="bookmark99">20% glycolic peel, 15% lactic peel, and topical 20% vitamin C in constitutional type of periorbital melanosis: a comparative study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref68" class="s35" target="_blank">J Cosmet Dermatol</a>. 2016;15:367-373<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref69" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">69. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref69" target="_blank">Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref69" class="a" target="_blank" name="bookmark100">glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref69" class="s35" target="_blank">Dermatol Surg</a>. 2002;28:828-832<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref70" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">70. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref70" target="_blank">Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref70" class="a" target="_blank">chemical peels as a new therapeutic modality in melasma in comparison to Jessner’s solution chemical peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref70" class="s35" target="_blank">Dermatol Surg</a>. 2006;32:1429-1436<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref71" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">71. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref71" class="a" target="_blank">Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid as a new therapeutic peeling agent in melasma. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref71" class="s35" target="_blank">Dermatol Surg</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref71" class="a" target="_blank">. </a>2005;31:149-154<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref72" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark101">72. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref72" class="a" target="_blank">Khunger N, Sarkar R, Jain RK. Tretinoin peels versus glycolic acid peels in the treatment of Melasma in dark-skinned patients. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref72" class="s35" target="_blank">Dermatol Surg</a>. 2004;30:756-760<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref73" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">73. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref73" target="_blank">Joshi SS, Boone SL, Alam M, et al. Effectiveness, safety, and</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref73" class="a" target="_blank">effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref73" class="s35" target="_blank">Dermatol Surg</a>. 2009;35:638-644<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref74" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">74. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref74" target="_blank">Tung R, Mahoney AM, Novice K, et al. Treatment of lateral</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref74" class="a" target="_blank">canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref74" class="s35" target="_blank">Int J Womens Dermatol</a>. 2016;2:31-34<span style=" color: #000;">.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s18" style="padding-top: 3pt;padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref75" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark102">75. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref75" class="a" target="_blank">Silpa-archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive over- view. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref75" class="s35" target="_blank">J Am Acad Dermatol</a>. 2017;77:591-605<span style=" color: #000;">.</span><a name="bookmark103">&zwnj;</a></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref76" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">76. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref76" target="_blank">Hevia O, Nemeth AJ, Taylor JR. Tretinoin accelerates healing</a></p><p class="s18" style="padding-left: 19pt;text-indent: 0pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref76" class="a" target="_blank" name="bookmark104">after trichloroacetic acid chemical peel. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref76" class="s35" target="_blank">Arch Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref76" class="a" target="_blank">. 1991; </a>127:678-682<span style=" color: #000;">.</span></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref77" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">77. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref77" class="a" target="_blank">Committee for Guidelines of Care for Chemical P. Guidelines for chemical peeling in Japan (3rd edition). </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref77" class="s35" target="_blank">J Dermatol</a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref77" class="a" target="_blank">. 2012; </a>39:321-325<span style=" color: #000;">.</span></p><p class="s18" style="padding-top: 3pt;padding-left: 19pt;text-indent: -13pt;line-height: 107%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref78" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank" name="bookmark105">78. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref78" class="a" target="_blank">Khunger N, Force IT. Standard guidelines of care for chemical peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref78" class="s35" target="_blank">Indian J Dermatol Venereol Leprol</a>. 2008;74(suppl):S5-S12<span style=" color: #000;">.</span><a name="bookmark106">&zwnj;</a></p><p class="s18" style="padding-left: 19pt;text-indent: -13pt;line-height: 108%;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref79" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">79. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref79" class="a" target="_blank">Garg VK, Sarkar R, Agarwal R. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref79" class="s35" target="_blank">Dermatol Surg</a>. 2008;34:1032-1039<span style=" color: #000;">.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 9pt;text-align: justify;"><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref80" style=" color: black; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt;" target="_blank">80. </a><a href="http://refhub.elsevier.com/S0190-9622(18)33049-4/sref80" target="_blank">Nanda S, Grover C, Reddy BS. Efficacy of hydroquinone (2%)</a></p><p class="nav">&nbsp;&nbsp;</p><p class="nav">&nbsp;</p><p class="nav"><a href="part31.htm">&lt; 上一个</a><span> | </span><a href="../j.jaad.2018.10.079.html">内容</a></p><p class="nav">&nbsp;&nbsp;</p></body></html>
